the recent spate of 3 acquisitions, while impressive, cost in excess of $32-Mil. On top of everything else going on expense wise, just how is AMBS going to pay for all of this, with NO REVENUE whatsoever and a money flowing out the door like the Amazon River? I'm certain there's quite a number of us who are sick and tired of hearing Gerald speak of "its just around the corner" and the proverbial carot in front of the horse sales pitches. LymPro has been held out to have the ability to bring us to the 'Promise Land' ever since Jan. 2013 BioMed Conf., where we slammed on the brakes and switched tracks from having a JV Partner, to waiting on CPT codes. Our expectations were again shatterted on July 31, on a world stage, when we got KOL news instead of S/S numbers, as had been promised. If you don't think these and many other misque's of Gerald's have casued the market to chill on this security, think again.
News 
Market Data 
Discover 
